Short Interest in iCoreConnect Inc. (NASDAQ:ICCT) Expands By 83.7%

iCoreConnect Inc. (NASDAQ:ICCT) was the recipient of a large increase in short interest in the month of November. As of November 15th, there was short interest totalling 203,000 shares, an increase of 83.7% from the October 31st total of 110,500 shares. Currently, 1.4% of the shares of the company are sold short. Based on an average daily volume of 3,900,000 shares, the short-interest ratio is presently 0.1 days.

iCoreConnect Stock Performance

NASDAQ ICCT traded up $0.00 during mid-day trading on Thursday, reaching $0.17. 426,959 shares of the stock were exchanged, compared to its average volume of 1,297,070. The company has a market capitalization of $4.16 million, a P/E ratio of -0.05 and a beta of 0.69. The company has a debt-to-equity ratio of 7.93, a quick ratio of 0.11 and a current ratio of 0.11. The business’s 50 day moving average is $0.28 and its 200-day moving average is $0.59. iCoreConnect has a 1 year low of $0.15 and a 1 year high of $3.20.

iCoreConnect Company Profile

iCoreConnect Inc, a cloud-based software and technology company, provides Health Insurance Portability and Accountability Act (HIPAA) compliant cloud-based software as a service (SaaS) in the United States. The company’s products include iCoreRx, a HIPAA compliant electronic prescription software; iCorePDMP, a solution that checks the patient’s Prescription Drug Monitoring Program (PDMP) history before prescribing controlled substances; iCoreVerify and iCoreVerify+, a HIPAA compliant SaaS solution that automatically retrieves a patients insurance eligibility breakdown to verify their benefits in advance of their appointment and on-demand; iCoreHuddle and iCoreHuddle+, a tool to instantly reveal the revenue potential of each patient; and iCoreCodeGenius, a medical coding reference SaaS solution.